Philadelphia, PA, United States of America

Josephine Giles

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Pennsylvania. Active years: 2024-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Josephine Giles: Innovator in T Cell Research

Introduction

Josephine Giles is a prominent inventor based in Philadelphia, PA. She has made significant contributions to the field of immunology, particularly in the study of exhausted T cells. Her innovative work has led to the development of methods and compositions that address diseases associated with these cells.

Latest Patents

Josephine Giles holds a patent for "Methods and compositions for treating diseases associated with exhausted T cells." This invention provides compositions and methods for detecting exhausted T cells in a subject. Additionally, it offers methods for treating individuals with diseases characterized by the presence of exhausted T cells or specific subpopulations thereof.

Career Highlights

Giles is affiliated with the University of Pennsylvania, where she conducts her research and develops her inventions. Her work has garnered attention for its potential impact on treating various diseases linked to immune system dysfunction.

Collaborations

Josephine has collaborated with notable colleagues, including E John Wherry and Bertram Bengsch. These partnerships have enhanced her research and contributed to advancements in the understanding of T cell exhaustion.

Conclusion

Josephine Giles is a trailblazer in the field of immunology, with her patent addressing critical health issues related to exhausted T cells. Her contributions continue to pave the way for innovative treatments and research in this vital area of medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…